Explore
Validate
Learn60007-1-Ig
antibody from Proteintech Group
Targeting: TGFBI
BIGH3, CDB1, CDGG1, CSD1, CSD2, CSD3, LCD1
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 60007-1-Ig - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#60007-1-Ig, RRID:AB_10896828
- Product name
- TGFBI / BIGH3 antibody
- Antibody type
- Monoclonal
- Description
- KD/KO validated TGFBI / BIGH3 antibody (Cat. #60007-1-Ig) is a mouse monoclonal antibody that shows reactivity with human and has been validated for the following applications: IF, IHC, IP, WB, ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 3E11D11
- Vial size
- 20ul, 150ul
Submitted references BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation.
Absence of Vitamin K-Dependent γ-Carboxylation in Human Periostin Extracted from Fibrotic Lung or Secreted from a Cell Line Engineered to Optimize γ-Carboxylation.
Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells.
Modified BIGH3 with an RGDRGD motif promotes human corneal epithelial cell adhesion and migration in vitro.
TGFbeta-induced protein mediates lymphatic endothelial cell adhesion to the extracellular matrix under low oxygen conditions.
Pan T, Lin SC, Yu KJ, Yu G, Song JH, Lewis VO, Bird JE, Moon B, Lin PP, Tannir NM, Jonasch E, Wood CG, Gallick GE, Yu-Lee LY, Lin SH, Satcher RL
Neoplasia (New York, N.Y.) 2018 Jan;20(1):32-43
Neoplasia (New York, N.Y.) 2018 Jan;20(1):32-43
Absence of Vitamin K-Dependent γ-Carboxylation in Human Periostin Extracted from Fibrotic Lung or Secreted from a Cell Line Engineered to Optimize γ-Carboxylation.
Annis DS, Ma H, Balas DM, Kumfer KT, Sandbo N, Potts GK, Coon JJ, Mosher DF
PloS one 2015;10(8):e0135374
PloS one 2015;10(8):e0135374
Transforming growth factor-beta-induced protein secreted by peritoneal cells increases the metastatic potential of ovarian cancer cells.
Ween MP, Lokman NA, Hoffmann P, Rodgers RJ, Ricciardelli C, Oehler MK
International journal of cancer 2011 Apr 1;128(7):1570-84
International journal of cancer 2011 Apr 1;128(7):1570-84
Modified BIGH3 with an RGDRGD motif promotes human corneal epithelial cell adhesion and migration in vitro.
Ge H, Cao W, Leng F, Chen W, Liu P, Chen W
Current eye research 2008 Mar;33(3):215-23
Current eye research 2008 Mar;33(3):215-23
TGFbeta-induced protein mediates lymphatic endothelial cell adhesion to the extracellular matrix under low oxygen conditions.
Irigoyen M, Ansó E, Salvo E, Dotor de las Herrerías J, Martínez-Irujo JJ, Rouzaut A
Cellular and molecular life sciences : CMLS 2008 Jul;65(14):2244-55
Cellular and molecular life sciences : CMLS 2008 Jul;65(14):2244-55
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The TGFBI / BIGH3 antibody from Proteintech is a mouse monoclonal antibody to a recombinant protein of human TGFBI / BIGH3. This antibody recognizes human, mouse antigen. The TGFBI / BIGH3 antibody has been validated for the following applications: ELISA, IHC, WB analysis.
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human kidney using 60007-1-Ig(BIGH3 antibody) at dilution of 1:50 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human kidney using 60007-1-Ig(BIGH3 antibody) at dilution of 1:50 (under 40x lens)
- Sample type
- tissue
